IMPROVE-IT study shows cardiovascular benefit

cholesterol: heart on ecg graph
The IMPROVE-IT study, the large cardiovascular-outcomes trial that showed a clinical benefit to adding ezetimibe to statin therapy in post–acute coronary syndrome patients, is now published. The trial included more than 18,000 patients showing that the combination of ezetimibe/simvastatin leads to fewer cardiovascular events (as measured by a composite of cardiovascular death, non-fatal myocardial infarction,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Bruce Elliot only pharmacist in Primary Health Care Advisory Group
Next Discount Drug Stores announces new services